BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1751367)

  • 1. Prognostic importance of Sudan Black positivity: a study of bone marrow slides from 1,386 patients with de novo acute myeloid leukaemia.
    Hoyle CF; Gray RG; Wheatley K; Swirsky D; de Bastos M; Sherrington P; Rees JK; Hayhoe FG
    Br J Haematol; 1991 Nov; 79(3):398-407. PubMed ID: 1751367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features affecting outcome during remission induction of acute myeloid leukaemia in 619 adult patients.
    Swirsky DM; de Bastos M; Parish SE; Rees JK; Hayhoe FG
    Br J Haematol; 1986 Nov; 64(3):435-53. PubMed ID: 3466640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission with morphological myelodysplasia in de novo acute myeloid leukaemia: implications for early relapse.
    Nagai K; Matsuo T; Atogami S; Moriuchi Y; Yoshida Y; Kuriyama K; Tomonaga M
    Br J Haematol; 1992 May; 81(1):33-9. PubMed ID: 1520622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between age and blast cell differentiation in acute myeloid leukaemia patients.
    Hassan HT; Rees JK
    Oncology; 1990; 47(5):439-42. PubMed ID: 2216301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of acute leukaemia by light and electron microscope cytochemistry.
    Jansson SE; Gripenberg J; Vuopio P; Teerenhovi L; Andersson LC
    Scand J Haematol; 1980 Nov; 25(5):412-6. PubMed ID: 7013019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
    Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
    J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia.
    Adida C; Recher C; Raffoux E; Daniel MT; Taksin AL; Rousselot P; Sigaux F; Degos L; Altieri DC; Dombret H
    Br J Haematol; 2000 Oct; 111(1):196-203. PubMed ID: 11091201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapy.
    Campos L; Guyotat D; Archimbaud E; Devaux Y; Treille D; Larese A; Maupas J; Gentilhomme O; Ehrsam A; Fiere D
    Br J Haematol; 1989 Jun; 72(2):161-6. PubMed ID: 2757962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of blood and marrow findings in acute myelogenous leukemia in remission. A Southeastern Cancer Study Group report.
    Vogler WR; Raney MR
    Cancer; 1988 Jun; 61(12):2481-6. PubMed ID: 3163256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO).
    Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
    Br J Haematol; 1991 Jul; 78(3):325-9. PubMed ID: 1651754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double esterase staining of the bone marrow contributes to lineage identification in a case of minimally differentiated acute myeloid leukaemia (AML M0).
    Elghetany MT
    Clin Lab Haematol; 1999 Aug; 21(4):293-5. PubMed ID: 10583335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basophils in acute myeloid leukaemia.
    Hoyle CF; Sherrington PD; Fischer P; Hayhoe FG
    J Clin Pathol; 1989 Aug; 42(8):785-92. PubMed ID: 2671051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213.
    Wells RJ; Arthur DC; Srivastava A; Heerema NA; Le Beau M; Alonzo TA; Buxton AB; Woods WG; Howells WB; Benjamin DR; Betcher DL; Buckley JD; Feig SA; Kim T; Odom LF; Ruymann FB; Smithson WA; Tannous R; Whitt JK; Wolff L; Tjoa T; Lampkin BC
    Leukemia; 2002 Apr; 16(4):601-7. PubMed ID: 11960339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudan Black B positivity in acute lymphoblastic leukaemia.
    Tricot G; Broeckaert-Van Orshoven A; Van Hoof A; Verwilghen RL
    Br J Haematol; 1982 Aug; 51(4):615-21. PubMed ID: 6179532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
    Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
    Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia.
    Liso V; Albano F; Pastore D; Carluccio P; Mele G; Lamacchia M; Mestice A; Specchia G
    Haematologica; 2000 Dec; 85(12):1285-90. PubMed ID: 11114136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.